McLean Hospital, Harvard Medical School, Belmont, MA, USA.
The Mellen Center for Multiple Sclerosis and Research, Department of Neurology, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Mult Scler. 2024 Nov;30(13):1642-1652. doi: 10.1177/13524585241282763. Epub 2024 Oct 17.
While standard clinical assessments provide great value for people with multiple sclerosis (PwMS), they are limited in their ability to characterize patient perspectives and individual-level symptom heterogeneity.
To identify PwMS subgroups based on patient-reported outcomes (PROs) of physical, cognitive, and emotional symptoms. We also sought to connect PRO-based subgroups with demographic variables, functional impairment, hypertension and smoking status, traditional qualitative multiple sclerosis (MS) symptom groupings, and neuroperformance measurements.
Using a cross-sectional design, we applied latent profile analysis (LPA) to a large database of PROs; analytic sample = 6619).
We identified nine distinct MS subtypes based on PRO patterns. The subtypes were primarily categorized into low, moderate, and high mobility impairment clusters. Approximately 70% of participants were classified in a low mobility impairment group, 10% in a moderate mobility impairment group, and 20% in a high mobility impairment group. Within these subgroups, several unexpected patterns were observed, such as high mobility impairment clusters reporting low non-mobility impairment.
The present study highlights an opportunity to advance precision medicine approaches in MS. Combining PROs with data-driven methodology allows for a cost-effective and personalized characterization of symptom presentations. that can inform clinical practice and future research designs.
尽管标准的临床评估对多发性硬化症(MS)患者具有重要价值,但它们在描述患者的观点和个体层面症状异质性方面存在局限性。
根据患者报告的身体、认知和情绪症状的结果(PROs),确定多发性硬化症患者的亚组。我们还试图将基于 PRO 的亚组与人口统计学变量、功能障碍、高血压和吸烟状况、传统的定性多发性硬化症(MS)症状分组以及神经表现测量联系起来。
使用横断面设计,我们对大量的 PRO 数据应用潜在剖面分析(LPA);分析样本=6619)。
我们根据 PRO 模式确定了九个不同的 MS 亚型。这些亚型主要分为低、中、高移动障碍集群。约 70%的参与者被归类为低移动障碍组,10%的参与者被归类为中移动障碍组,20%的参与者被归类为高移动障碍组。在这些亚组中,观察到了一些出乎意料的模式,例如高移动障碍集群报告的非移动障碍较低。
本研究强调了在多发性硬化症中推进精准医学方法的机会。将 PROs 与数据驱动的方法相结合,可以对症状表现进行具有成本效益的个性化描述,从而为临床实践和未来的研究设计提供信息。